IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0018391.html
   My bibliography  Save this article

Determinants of the Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants and Children

Author

Listed:
  • Amanda Ross
  • Nicolas Maire
  • Elisa Sicuri
  • Thomas Smith
  • Lesong Conteh

Abstract

Background: Trials of intermittent preventive treatment in infants (IPTi) and children (IPTc) have shown promising results in reducing malaria episodes but with varying efficacy and cost-effectiveness. The effects of different intervention and setting characteristics are not well known. We simulate the effects of the different target age groups and delivery channels, seasonal or year-round delivery, transmission intensity, seasonality, proportions of malaria fevers treated and drug characteristics. Methods: We use a dynamic, individual-based simulation model of Plasmodium falciparum malaria epidemiology, antimalarial drug action and case management to simulate DALYs averted and the cost per DALY averted by IPTi and IPTc. IPT cost components were estimated from economic studies alongside trials. Results: IPTi and IPTc were predicted to be cost-effective in most of the scenarios modelled. The cost-effectiveness is driven by the impact on DALYs, particularly for IPTc, and the low costs, particularly for IPTi which uses the existing delivery strategy, EPI. Cost-effectiveness was predicted to decrease with low transmission, badly timed seasonal delivery in a seasonal setting, short-acting and more expensive drugs, high frequencies of drug resistance and high levels of treatment of malaria fevers. Seasonal delivery was more cost-effective in seasonal settings, and year-round in constant transmission settings. The difference was more pronounced for IPTc than IPTi due to the different proportions of fixed costs and also different assumed drug spacing during the transmission season. The number of DALYs averted was predicted to decrease as a target five-year age-band for IPTc was shifted from children under 5 years into older ages, except at low transmission intensities. Conclusions: Modelling can extend the information available by predicting impact and cost-effectiveness for scenarios, for outcomes and for multiple strategies where, for practical reasons, trials cannot be carried out. Both IPTi and IPTc are generally cost-effective but could be rendered cost-ineffective by characteristics of the setting, drug or implementation.

Suggested Citation

  • Amanda Ross & Nicolas Maire & Elisa Sicuri & Thomas Smith & Lesong Conteh, 2011. "Determinants of the Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants and Children," PLOS ONE, Public Library of Science, vol. 6(4), pages 1-12, April.
    • Handle: RePEc:plo:pone00:0018391
    DOI: 10.1371/journal.pone.0018391
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0018391
    Download Restriction: no
    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0018391&type=printable
    Download Restriction: no
    File URL: https://libkey.io/10.1371/journal.pone.0018391?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Asenso-Okyere, W. K. & Dzator, Janet A., 1997. "Household cost of seeking malaria care. A retrospective study of two districts in Ghana," Social Science & Medicine, Elsevier, vol. 45(5), pages 659-667, September.
    2. Samuel Shillcutt & Damian Walker & Catherine Goodman & Anne Mills, 2009. "Cost Effectiveness in Low- and Middle-Income Countries," PharmacoEconomics, Springer, vol. 27(11), pages 903-917, November.
    3. Kalifa A Bojang & Francis Akor & Lesong Conteh & Emily Webb & Ousman Bittaye & David J Conway & Momodou Jasseh & Virginia Wiseman & Paul J Milligan & Brian Greenwood, 2011. "Two Strategies for the Delivery of IPTc in an Area of Seasonal Malaria Transmission in The Gambia: A Randomised Controlled Trial," PLOS Medicine, Public Library of Science, vol. 8(2), pages 1-14, February.
    4. Arnesen, Trude & Kapiriri, Lydia, 2004. "Can the value choices in DALYs influence global priority-setting?," Health Policy, Elsevier, vol. 70(2), pages 137-149, November.
    5. World Bank, 1993. "World Development Report 1993," World Bank Publications - Books, The World Bank Group, number 5976.
    6. Alan D. Lopez & Colin D. Mathers & Majid Ezzati & Dean T. Jamison & Christopher J. L. Murray, 2006. "Global Burden of Disease and Risk Factors," World Bank Publications - Books, The World Bank Group, number 7039.
    7. Anand, Sudhir & Hanson, Kara, 1997. "Disability-adjusted life years: a critical review," Journal of Health Economics, Elsevier, vol. 16(6), pages 685-702, December.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Resign Gunda & Moses John Chimbari & Samson Mukaratirwa, 2016. "Assessment of Burden of Malaria in Gwanda District, Zimbabwe, Using the Disability Adjusted Life Years," IJERPH, MDPI, vol. 13(2), pages 1-12, February.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Martine AUDIBERT & Pascale COMBES MOTEL & Alassane DRABO, 2010. "Global Burden of Disease and Economic Growth," Working Papers 201036, CERDI.
    2. Lesong Conteh & Elisa Sicuri & Fatuma Manzi & Guy Hutton & Benson Obonyo & Fabrizio Tediosi & Prosper Biao & Paul Masika & Fred Matovu & Peter Otieno & Roly D Gosling & Mary Hamel & Frank O Odhiambo &, 2010. "The Cost-Effectiveness of Intermittent Preventive Treatment for Malaria in Infants in Sub-Saharan Africa," PLOS ONE, Public Library of Science, vol. 5(6), pages 1-7, June.
    3. Murray, Christopher J. L. & Acharya, Arnab K., 1997. "Understanding DALYs," Journal of Health Economics, Elsevier, vol. 16(6), pages 703-730, December.
    4. Elisa Sicuri & Silke Fernandes & Eusebio Macete & Raquel González & Ghyslain Mombo-Ngoma & Achille Massougbodgi & Salim Abdulla & August Kuwawenaruwa & Abraham Katana & Meghna Desai & Michel Cot & Mic, 2015. "Economic Evaluation of an Alternative Drug to Sulfadoxine-Pyrimethamine as Intermittent Preventive Treatment of Malaria in Pregnancy," PLOS ONE, Public Library of Science, vol. 10(4), pages 1-23, April.
    5. Merwan Engineer & Nilanjana Roy & Sari Fink, 2010. "“Healthy” Human Development Indices," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 99(1), pages 61-80, October.
    6. Andrea Klonschinski, 2021. "Universal Metrics for Climate Change Adaptation Finance? A Cautionary Tale," Sustainability, MDPI, vol. 13(16), pages 1-14, August.
    7. Stephanie Bogdewic & Rohit Ramaswamy & David M Goodman & Emmanuel K Srofenyoh & Sebnem Ucer & Medge D Owen, 2020. "The cost-effectiveness of a program to reduce intrapartum and neonatal mortality in a referral hospital in Ghana," PLOS ONE, Public Library of Science, vol. 15(11), pages 1-18, November.
    8. Martine Audibert & Pascale Combes Motel & Alassane Drabo, 2013. "Health capital depreciation effects on development: theory and measurement," CERDI Working papers halshs-00832877, HAL.
    9. James Buchanan & Borislava Mihaylova & Alastair Gray & Nicholas White, 2010. "Cost-Effectiveness of Pre-Referral Antimalarial, Antibacterial, and Combined Rectal Formulations for Severe Febrile Illness," PLOS ONE, Public Library of Science, vol. 5(12), pages 1-12, December.
    10. Blake C Alkire & Jeffrey R Vincent & Christy Turlington Burns & Ian S Metzler & Paul E Farmer & John G Meara, 2012. "Obstructed Labor and Caesarean Delivery: The Cost and Benefit of Surgical Intervention," PLOS ONE, Public Library of Science, vol. 7(4), pages 1-10, April.
    11. Kapiriri, Lydia, 2013. "How effective has the essential health package been in improving priority setting in low income countries?," Social Science & Medicine, Elsevier, vol. 85(C), pages 38-42.
    12. Marcello Basili & Filippo Belloc, 2015. "How To Measure The Economic Impact Of Vector-Borne Diseases At Country Level," Journal of Economic Surveys, Wiley Blackwell, vol. 29(5), pages 896-916, December.
    13. Brecht Devleesschauwer & Arie Havelaar & Charline Maertens de Noordhout & Juanita Haagsma & Nicolas Praet & Pierre Dorny & Luc Duchateau & Paul Torgerson & Herman Oyen & Niko Speybroeck, 2014. "Calculating disability-adjusted life years to quantify burden of disease," International Journal of Public Health, Springer;Swiss School of Public Health (SSPH+), vol. 59(3), pages 565-569, June.
    14. Samuel Shillcutt & Damian Walker & Catherine Goodman & Anne Mills, 2009. "Cost Effectiveness in Low- and Middle-Income Countries," PharmacoEconomics, Springer, vol. 27(11), pages 903-917, November.
    15. Anderson, Soren T. & Laxminarayan, Ramanan & Salant, Stephen W., 2012. "Diversify or focus? Spending to combat infectious diseases when budgets are tight," Journal of Health Economics, Elsevier, vol. 31(4), pages 658-675.
    16. Hunt-McCool, Janet & Bishop, Dawn M., 1998. "Health economics and the economics of education: specialization and division of labor," Economics of Education Review, Elsevier, vol. 17(3), pages 237-244, June.
    17. Tarp, Finn & Simler, Kenneth R. & Matusse, Cristina & Heltberg, Rasmus & Dava, Gabriel, 2002. "The robustness of poverty profiles reconsidered," FCND discussion papers 126, International Food Policy Research Institute (IFPRI).
    18. Juliana Martins Ruzante & Valerie J. Davidson & Julie Caswell & Aamir Fazil & John A. L. Cranfield & Spencer J. Henson & Sven M. Anders & Claudia Schmidt & Jeffrey M. Farber, 2010. "A Multifactorial Risk Prioritization Framework for Foodborne Pathogens," Risk Analysis, John Wiley & Sons, vol. 30(5), pages 724-742, May.
    19. John Gibson & Steven Stillman & David McKenzie & Halahingano Rohorua, 2013. "Natural Experiment Evidence On The Effect Of Migration On Blood Pressure And Hypertension," Health Economics, John Wiley & Sons, Ltd., vol. 22(6), pages 655-672, June.
    20. Eva Deuchert, 2011. "The Virgin HIV Puzzle: Can Misreporting Account for the High Proportion of HIV Cases in Self-reported Virgins?," Journal of African Economies, Centre for the Study of African Economies, vol. 20(1), pages 60-89, January.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0018391. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.